Sections

Skip to main content

Home
Issues
- Issue Archive
Topics
Conference Correspondent
Multimedia
- Videos
- Interview with the Innovators
Editorial Board
About

Home
Issues
- Issue Archive
Topics
Conference Correspondent
Multimedia
- Videos
- Interview with the Innovators
Editorial Board
About

A Nurse Navigator’s Perspective on CDK4/6 Inhibitors

Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

A Payer’s Perspective on CDK4/6 Inhibitors

Kenneth L. Schaecher, MD, FACP, CPC

A Pharmacist’s Perspective on CDK4/6 Inhibitors

Robert C. Wolf, PharmD

Breast Cancer, Oncology

Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer

Results 1 - 4 of 4

SUBSCRIBE

HOME
ABOUT
CONTACT US
TERMS OF USE
PRIVACY POLICY
ADVERTISING POLICY

© Amplity, Inc. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Special Print Editions

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.